Hendrik Bläker

6.1k total citations
136 papers, 3.6k citations indexed

About

Hendrik Bläker is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Hendrik Bläker has authored 136 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 60 papers in Pathology and Forensic Medicine and 49 papers in Surgery. Recurrent topics in Hendrik Bläker's work include Genetic factors in colorectal cancer (54 papers), Colorectal Cancer Screening and Detection (26 papers) and Cancer Genomics and Diagnostics (21 papers). Hendrik Bläker is often cited by papers focused on Genetic factors in colorectal cancer (54 papers), Colorectal Cancer Screening and Detection (26 papers) and Cancer Genomics and Diagnostics (21 papers). Hendrik Bläker collaborates with scholars based in Germany, United States and Switzerland. Hendrik Bläker's co-authors include Matthias Kloor, Magnus von Knebel Doeberitz, Wilfried Roth, Hermann Brenner, Michael Hoffmeister, Herwart F. Otto, Peter Schirmacher, Jenny Chang‐Claude, Lina Jansen and Roland Penzel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Hendrik Bläker

129 papers receiving 3.5k citations

Peers

Countries citing papers authored by Hendrik Bläker

Since Specialization

Citations

This map shows the geographic impact of Hendrik Bläker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Bläker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Bläker more than expected).

Fields of papers citing papers by Hendrik Bläker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hendrik Bläker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Bläker. The network helps show where Hendrik Bläker may publish in the future.

Co-authorship network of co-authors of Hendrik Bläker

This figure shows the co-authorship network connecting the top 25 collaborators of Hendrik Bläker. A scholar is included among the top collaborators of Hendrik Bläker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hendrik Bläker. Hendrik Bläker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of immune evasion in myeloid sarcomas with disease manifestation and patients’ survival 2024 ·Frontiers in Immunology ·Marcus Bauer, (unknown), Hubert Hackl, (unknown), Nadja Jaekel, Hendrik Bläker, Haifa Kathrin Al‐Ali, Barbara Seliger, Claudia Wickenhauser	0
2	Alveolar Echinococcosis – Diagnostic challenges of a parasitic disease on the rise in Europe – a case report 2024 ·Zeitschrift für Gastroenterologie ·(unknown), Henning Trawinski, Hans‐Michael Tautenhahn, Hendrik Bläker, Johannes Wiegand	1
3	CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: A systematic review and external validation study 2023 ·Critical Reviews in Oncology/Hematology ·Tanwei Yuan, Dominic Edelmann, Jakob Nikolas Kather, Ziwen Fan, Katrin E. Tagscherer, Wilfried Roth, Melanie Bewerunge‐Hudler, Alexander Brobeil, Matthias Kloor, Hendrik Bläker, Barbara Burwinkel, Hermann Brenner, Michael Hoffmeister	2
4	Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis 2023 ·Zeitschrift für Gastroenterologie ·(unknown), (unknown), (unknown), (unknown), (unknown), Hendrik Bläker, Johannes Wiegand	1
5	Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study 2022 ·Journal of Cancer Research and Clinical Oncology ·Boris Jansen‐Winkeln, (unknown), Yusef Moulla, Matthias Mehdorn, Stefan Niebisch, Katrin Schierle, Hendrik Bläker, Florian Lordick, Ines Gockel, René Thieme	4
6	Improving one-step scarless genome editing in Drosophila melanogaster by combining ovoD co-CRISPR selection with sgRNA target site masking 2022 ·Biology Methods and Protocols ·(unknown), (unknown), (unknown), Knut Krohn, Diana Le Duc, (unknown), Mathias A. Böhme, Manfred Heckmann, Rami Abou Jamra, Johannes R. Lemke, Hendrik Bläker, Nicole Scholz, Dmitrij Ljaschenko, Tobias Langenhan	0
7	Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study 2022 ·Journal of Cancer Research and Clinical Oncology ·Katharina Kolbe, (unknown), Katrin Schierle, Dieter Maier, (unknown), Birgit Luber, Hendrik Bläker, Christian Wittekind, Florian Lordick	3
8	A computational model for investigating the evolution of colonic crypts during Lynch syndrome carcinogenesis 2021 ·SHILAP Revista de lepidopterología ·Saskia Haupt, (unknown), Aysel Ahadova, Hendrik Bläker, Magnus von Knebel Doeberitz, Matthias Kloor, Vincent Heuveline	0
9	Colonoscopy and Reduction of Colorectal Cancer Risk by Molecular Tumor Subtypes: A Population-Based Case-Control Study 2020 ·The American Journal of Gastroenterology ·Michael Hoffmeister, Hendrik Bläker, Lina Jansen, Elizabeth Alwers, Efrat L. Amitay, Prudence R. Carr, Matthias Kloor, Esther Herpel, Wilfried Roth, Jenny Chang‐Claude, Hermann Brenner	14
10	Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? 2020 ·European Radiology ·Timo Alexander Auer, Uli Fehrenbach, Christian Grieser, Tobias Penzkofer, Dominik Geisel, Moritz Schmelzle, Tobias Müller, Hendrik Bläker, Daniel Seehofer, Timm Denecke	29
11	The majority of β-catenin mutations in colorectal cancer is homozygous 2020 ·BMC Cancer ·Alexander Arnold, (unknown), Christine Sers, Aysel Ahadova, Volker Endris, Soulafa Mamlouk, David Horst, Markus Möbs, Philip Bischoff, Matthias Kloor, Hendrik Bläker	28
12	Association of BMI and major molecular pathological markers of colorectal cancer in men and women 2019 ·American Journal of Clinical Nutrition ·Prudence R. Carr, Efrat L. Amitay, Lina Jansen, Elizabeth Alwers, Wilfried Roth, Esther Herpel, Matthias Kloor, Martin Schneider, Hendrik Bläker, Jenny Chang‐Claude, Hermann Brenner, Michael Hoffmeister	12
13	TP53 mutation predicts sensitivity to adjuvant gemcitabine in pancreatic cancer: Results from the CONKO-001 study 2017 ·Annals of Oncology ·M. Sinn, Jan Budczies, Frédérik Damm, Philipp Lohneis, Rosa Schmuck, Denise Treue, Jana K. Striefler, Marcus Bahra, Uwe Pelzer, (unknown), Hendrik Bläker, Sven Bischoff, Helmut Oettle, Carsten Denkert, Hanno Riess, (unknown)	3
14	MACC1 Induces Tumor Progression in Transgenic Mice and Colorectal Cancer Patients via Increased Pluripotency Markers Nanog and Oct4 2016 ·Clinical Cancer Research ·Clara Lemos, Markus Hardt, Manisha Juneja, (unknown), Susann Förster, Boris Jerchow, W. Haider, Hendrik Bläker, Ulrike Stein	43
15	Alcohol consumption and survival of colorectal cancer patients: a population-based study from Germany 2016 ·American Journal of Clinical Nutrition ·Viola Walter, Lina Jansen, Alexis Ulrich, Wilfried Roth, Hendrik Bläker, Jenny Chang‐Claude, Michael Hoffmeister, Hermann Brenner	50
16	A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics 2015 ·Cancer Discovery ·Anguraj Sadanandam, Stephan Wullschleger, Costas A. Lyssiotis, Carsten Grötzinger, Stefano Barbi, Samantha Bersani, (unknown), (unknown), Andrea Mafficini, Rita T. Lawlor, Michele Simbolo, John M. Asara, Hendrik Bläker, Lewis C. Cantley, Bertram Wiedenmann, Aldo Scarpa, Douglas Hanahan	139
17	Associations of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment 2015 ·American Journal of Clinical Nutrition ·Prudence R. Carr, Lina Jansen, Viola Walter, Matthias Kloor, Wilfried Roth, Hendrik Bläker, Jenny Chang‐Claude, Hermann Brenner, Michael Hoffmeister	30
18	Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMP 2011 ·Modern Pathology ·Arne Warth, Matthias Kloor, Peter Schirmacher, Hendrik Bläker	37
19	Villöses Urachusdivertikeladenom mit Langzeitmukusurie 2008 ·Der Pathologe ·Stephan Macher‐Goeppinger, Sebastian Aulmann, Axel Haferkamp, Markus Hohenfellner, Peter Schirmacher, Hendrik Bläker	2
20	Cystic lymphangioma of the small-bowel mesentery 2000 ·Pathology & Oncology Research ·Ralf J. Rieker, Armin Quentmeier, (unknown), (unknown), Kerstin Amann, Gunhild Mechtersheimer, Hendrik Bläker, Herwart F. Otto	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact